# NUVAXOVID 2026-27

NDC: 49281-026
Generic name: NVX-COV2928
Labeler / Manufacturer: Sanofi Vaccines US Inc.
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRAMUSCULAR
Marketing started: 20260827

FDA application: BLA125817

## Active ingredients

- NVX-COV2928: 5 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49281-026"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49281-026